Autophagy promotes paclitaxel resistance of cervical cancer cells: Involvement of Warburg effect activated hypoxia-induced factor 1-α-mediated signaling

Cell Death and Disease

Volumn 5, Issue 8, 2014, Pages

  Peng, X ^a   Gong, F ^a,b   Chen, Y ^a   Jiang, Y ^a   Liu, J ^a   Yu, M ^a   Zhang, S ^a   Wang, M ^a   Xiao, G ^c   Liao, H ^d  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c ZUNYI MEDICAL UNIVERSITY   (China)

^d WENZHOU CENTRAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3-METHYLADENINE; ADENINE; ANTINEOPLASTIC AGENT; ATG7 PROTEIN, HUMAN; AUTOPHAGY RELATED PROTEIN 7; DEOXYGLUCOSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; KONINGIC ACID; LIGHT CHAIN 3, HUMAN; MICROTUBULE ASSOCIATED PROTEIN; PACLITAXEL; SESQUITERPENE; UBIQUITIN PROTEIN LIGASE;

ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; AUTOPHAGY; DOWN REGULATION; DRUG EFFECTS; DRUG RESISTANCE; FEMALE; GENETICS; GLYCOLYSIS; HELA CELL LINE; HUMAN; METABOLISM; PATHOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; UPREGULATION; UTERINE CERVIX TUMOR;

ADENINE; ANTINEOPLASTIC AGENTS, PHYTOGENIC; AUTOPHAGY; AUTOPHAGY-RELATED PROTEIN 7; DEOXYGLUCOSE; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; FEMALE; GLYCOLYSIS; HELA CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICROTUBULE-ASSOCIATED PROTEINS; PACLITAXEL; RNA INTERFERENCE; SESQUITERPENES; SIGNAL TRANSDUCTION; UBIQUITIN-ACTIVATING ENZYMES; UP-REGULATION; UTERINE CERVICAL NEOPLASMS;

EID: 84906847822     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.297     Document Type: Article

References (42)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. Cancer J Clin 2010; 60: 277-300.
2. Pectasides D, Kamposioras K, Papaxoinis G, Pectasides E. Chemotherapy for recurrent cervical cancer. Cancer Treatment Rev 2008; 34: 603-613.
3. Frankel A, Buckman R, Kerbel RS. Abrogation of taxol-induced G2-M arrest and apoptosis in human ovarian cancer cells grown as multicellular tumor spheroids. Cancer Res 1997; 57: 2388-2393.
4. Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 1993; 62: 385-427.
5. Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2002; 2: 48-58.
6. Szakacs G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM. Targeting multidrug resistance in cancer. Nat Rev Drug Discov 2006; 5: 219-234.
7. Goncalves A, Braguer D, Kamath K, Martello L, Briand C, Horwitz S et al. Resistance to Taxol in lung cancer cells associated with increased microtubule dynamics. Proc Natl Acad Sci USA 2001; 98: 11737-11742.
8. Kavallaris M, Kuo DY, Burkhart CA, Regl DL, Norris MD, Haber M et al. Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes. J Clin Invest 1997; 100: 1282-1293.
9. Tan M, Jing T, Lan KH, Neal CL, Li P, Lee S et al. Phosphorylation on tyrosine-15 of p34(Cdc2) by ErbB2 inhibits p34(Cdc2) activation and is involved in resistance to taxol-induced apoptosis. Mol Cell 2002; 9: 993-1004.
10. Lu J, Tan M, Huang WC, Li P, Guo H, Tseng LM et al. Mitotic deregulation by survivin in ErbB2-overexpressing breast cancer cells contributes to taxol resistance. Clin Cancer Res 2009; 15: 1326-1334.
11. Ajabnoor GM, Crook T, Coley HM. Paclitaxel resistance is associated with switch from apoptotic to autophagic cell death in MCF-7 breast cancer cells. Cell death dis 2012; 3: e260.
12. Mizushima N, Levine B, Cuervo AM, Klionsky DJ. Autophagy fights disease through cellular self-digestion. Nature 2008; 451: 1069-1075.
13. Levine B, Klionsky DJ. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev cell 2004; 6: 463-477.
14. Pyo JO, Jang MH, Kwon YK, Lee HJ, Jun JI, Woo HN et al. Essential roles of Atg5 and FADD in autophagic cell death: dissection of autophagic cell death into vacuole formation and cell death. J Biological Chemistry 2005; 280: 20722-20729.
15. Pattingre S, Tassa A, Qu X, Garuti R, Liang XH, Mizushima N et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005; 122: 927-939.
16. Melendez A, Talloczy Z, Seaman M, Eskelinen EL, Hall DH, Levine B. Autophagy genes are essential for dauer development and life-span extension in C. elegans. Science 2003; 301: 1387-1391.
17. Yu L, Alva A, Su H, Dutt P, Freundt E, Welsh S et al. Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 2004; 304: 1500-1502.
18. Petiot A, Ogier-Denis E, Blommaart EF, Meijer AJ, Codogno P. Distinct classes of phosphatidylinositol 3'-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells. J Biol Chem 2000; 275: 992-998.
19. Hashimoto D, Ohmuraya M, Hirota M, Yamamoto A, Suyama K, Ida S et al. Involvement of autophagy in trypsinogen activation within the pancreatic acinar cells. J Cell Biol 2008; 181: 1065-1072.
20. Kondo Y, Kanzawa T, Sawaya R, Kondo S. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 2005; 5: 726-734.
21. Li J, Hou N, Faried A, Tsutsumi S, Kuwano H. Inhibition of autophagy augments 5-fluorouracil chemotherapy in human colon cancer in vitro and in vivo model. Eur J Cancer 2010; 46: 1900-1909.
22. Apel A, Herr I, Schwarz H, Rodemann HP, Mayer A. Blocked autophagy sensitizes resistant carcinoma cells to radiation therapy. Cancer Res 2008; 68: 1485-1494.
23. Komatsu M, Waguri S, Ueno T, Iwata J, Murata S, Tanida I et al. Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J Cell Biol 2005; 169: 425-434.
24. Zhou M, Zhao Y, Ding Y, Liu H, Liu Z, Fodstad O et al. Warburg effect in chemosensitivity: targeting lactate dehydrogenase-A re-sensitizes taxol-resistant cancer cells to taxol. Mol Cancer 2010; 9: 33.
25. Semenza GL, Jiang BH, Leung SW, Passantino R, Concordet JP, Maire P et al. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem 1996; 271: 32529-32537.
26. Lu H, Forbes RA, Verma A. Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J Biol Chem 2002; 277: 23111-23115.
27. Christofk HR, Vander Heiden MG, Wu N, Asara JM, Cantley LC. Pyruvate kinase M2 is a phosphotyrosine-binding protein. Nature 2008; 452: 181-186.
28. Annibaldi A, Widmann C. Glucose metabolism in cancer cells. Curr Opin Clin Nutr Metab Care 2010; 13: 466-470.
29. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009; 324: 1029-1033.
30. Bensinger SJ, Christofk HR. New aspects of the Warburg effect in cancer cell biology. Sem Cell Dev Biol 2012; 23: 352-361.
31. Gillies RJ, Robey I, Gatenby RA. Causes and consequences of increased glucose metabolism of cancers. J Nuclear Med 2008; 49(Suppl 2): 24S-42S.
32. Shi HS, Li D, Zhang J, Wang YS, Yang L, Zhang HL et al. Silencing of pkm2 increases the efficacy of docetaxel in human lung cancer xenografts in mice. Cancer Sci 2010; 101: 1447-1453.
33. Guo W, Zhang Y, Chen T, Wang Y, Xue J, Xiao W et al. Efficacy of RNAi targeting of pyruvate kinase M2 combined with cisplatin in a lung cancer model. J Cancer Res Clin Oncol 2011; 137: 65-72.
34. Wang GL, Semenza GL. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 1995; 270: 1230-1237.
35. Akakura N, Kobayashi M, Horiuchi I, Suzuki A, Wang J, Chen J et al. Constitutive expression of hypoxia-inducible factor-1alpha renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation. Cancer Res 2001; 61: 6548-6554.
36. Kung AL, Wang S, Klco JM, Kaelin WG, Livingston DM. Suppression of tumor growth through disruption of hypoxia-inducible transcription. Nat Med 2000; 6: 1335-1340.
37. Zhong H, Chiles K, Feldser D, Laughner E, Hanrahan C, Georgescu MM et al. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res 2000; 60: 1541-1545.
38. Richard DE, Berra E, Pouyssegur J. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J Biol Chem 2000; 275: 26765-26771.
39. Qu X, Qing L. Abrin induces HeLa cell apoptosis by cytochrome c release and caspase activation. J Biochem Mol Biol 2004; 37: 445-453.
40. Li Q, Wei YQ, Wen YJ, Zhao X, Tian L, Yang L et al. Induction of apoptosis and tumor regression by vesicular stomatitis virus in the presence of gemcitabine in lung cancer. Int J Cancer 2004; 112: 143-149.
41. Kessler J, Hahnel A, Wichmann H, Rot S, Kappler M, Bache M et al. HIF-1alpha inhibition by siRNA or chetomin in human malignant glioma cells: effects on hypoxic radioresistance and monitoring via CA9 expression. BMC Cancer 2010; 10: 605.
42. Lavieu G, Scarlatti F, Sala G, Carpentier S, Levade T, Ghidoni R et al. Regulation of autophagy by sphingosine kinase 1 and its role in cell survival during nutrient starvation. J Biol Chem 2006; 281: 8518-8527.